Lipid nanoparticles
WO2026141629A1PCT designated stage Publication Date: 2026-07-02NITTO DENKO CORP
Patent Information
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- NITTO DENKO CORP
- Filing Date
- 2025-12-26
- Publication Date
- 2026-07-02
Smart Images
Figure JPOXMLDOC01-APPB-C000001 
Figure JPOXMLDOC01-APPB-C000002 
Figure JPOXMLDOC01-APPB-C000003
Abstract
The purpose of the present invention is to provide lipid nanoparticles that make it possible to efficiently introduce a drug into a cell, and a constituent lipid constituting the aforementioned lipid nanoparticles. Provided are lipid nanoparticles comprising a nucleic acid encapsulated in the lipid nanoparticles, a cationic lipid, and a targeting polyalkylene-glycol-modified lipid linked to a target binding site, the target binding site targeting a target site on a target cell.
Need to check novelty before this filing date? Find Prior Art